Overexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma
- PMID: 22977532
- PMCID: PMC3440741
- DOI: 10.3892/etm.2011.229
Overexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma
Abstract
Engulfment and cell motility 1 (Elmo1) has been linked to the invasive phenotype of glioma cells. The use of Elmo1 inhibitors is currently being evaluated in hepato-cellular carcinoma (HCC), but the molecular mechanisms of their therapeutic effect have yet to be determined. Elmo1 expression in HCC tissue samples from 131 cases and in 5 HCC cell lines was determined by immunohistochemistry, quantitative RT-PCR and Western blotting. To functionally characterize Elmo1 in HCC, Elmo1 expression in the HCCLM3 cell line was blocked by siRNA. Cell migration was measured by wound healing and transwell migration assays in vitro. Elmo1 overexpression was significantly correlated with cell invasion and the poor prognosis of HCC. Elmo1-siRNA-treated HCCLM3 cells demonstrated a reduction in cell migration. The present study demonstrated for the first time that the suppression of Elmo1 expression inhibits cell invasion in HCC.
Figures



Similar articles
-
Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis.Open Med (Wars). 2023 May 25;18(1):20230708. doi: 10.1515/med-2023-0708. eCollection 2023. Open Med (Wars). 2023. PMID: 37251542 Free PMC article.
-
Engulfment and cell motility 1 promotes tumor progression via the modulation of tumor cell survival in gastric cancer.Am J Transl Res. 2020 Dec 15;12(12):7797-7811. eCollection 2020. Am J Transl Res. 2020. PMID: 33437361 Free PMC article.
-
Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma.Onco Targets Ther. 2019 Aug 6;12:6203-6216. doi: 10.2147/OTT.S213833. eCollection 2019. Onco Targets Ther. 2019. PMID: 31498334 Free PMC article.
-
Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma.Onco Targets Ther. 2016 Apr 18;9:2227-36. doi: 10.2147/OTT.S96510. eCollection 2016. Onco Targets Ther. 2016. PMID: 27143918 Free PMC article.
-
Role of ELMO1 in inflammation and cancer-clinical implications.Cell Oncol (Dordr). 2022 Aug;45(4):505-525. doi: 10.1007/s13402-022-00680-x. Epub 2022 Jun 6. Cell Oncol (Dordr). 2022. PMID: 35668246 Review.
Cited by
-
MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells.J Cancer. 2019 Jun 9;10(15):3407-3419. doi: 10.7150/jca.30858. eCollection 2019. J Cancer. 2019. PMID: 31293644 Free PMC article.
-
Overexpression of Dock180 and Elmo1 in Melanoma is Associated with Cell Survival and Migration.Ann Dermatol. 2023 Dec;35(6):439-450. doi: 10.5021/ad.23.023. Ann Dermatol. 2023. PMID: 38086358 Free PMC article.
-
Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis.Open Med (Wars). 2023 May 25;18(1):20230708. doi: 10.1515/med-2023-0708. eCollection 2023. Open Med (Wars). 2023. PMID: 37251542 Free PMC article.
-
Knockdown of ELMO3 Suppresses Growth, Invasion and Metastasis of Colorectal Cancer.Int J Mol Sci. 2016 Dec 16;17(12):2119. doi: 10.3390/ijms17122119. Int J Mol Sci. 2016. PMID: 27999268 Free PMC article.
-
Engulfment and cell motility 1 promotes tumor progression via the modulation of tumor cell survival in gastric cancer.Am J Transl Res. 2020 Dec 15;12(12):7797-7811. eCollection 2020. Am J Transl Res. 2020. PMID: 33437361 Free PMC article.
References
-
- He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124–1134. - PubMed
-
- Hubert C, Sempoux C, Rahier J, Horsmans Y, Geubel A, van Beers BE, Annet L, Zech F, Leonard D, Gigot JF. Prognostic risk factors of survival after resection of hepatocellular carcinoma. Hepatogastroenterology. 2007;54:1791–1797. - PubMed
-
- Ibrahim S, Roychowdhury A, Hean TK. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Am J Surg. 2007;194:17–22. - PubMed
-
- Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer. 2007;43:979–992. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous